LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article: Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?

    Kembuan, Gabriele Jessica

    IDCases

    2020  Volume 22, Page(s) e00927

    Abstract: Dengue fever is an extremely common infection in Indonesia, with an estimated 77.96 cases / 100.000 person-years in 2016. However, in 2020 the threat of extremely contagious SARS CoV-2 or COVID-19 in Indonesia emerged, which has infected more than 100 ... ...

    Abstract Dengue fever is an extremely common infection in Indonesia, with an estimated 77.96 cases / 100.000 person-years in 2016. However, in 2020 the threat of extremely contagious SARS CoV-2 or COVID-19 in Indonesia emerged, which has infected more than 100.303 persons by July 28, 2020, and expected to grow exponentially except if very strict measures were implemented. There are similar symptoms and laboratory findings with both dengue fever and COVID-19, paving way to dangerous possibilities such as incorrect or delayed initial treatment. This is especially worrisome in the context of the pandemic, where COVID-19 positive patients must be promptly identified, isolated and contact-traced, and eluded diagnosis might possibly endanger communities and healthcare workers. We present cases of patients who initially presented with symptoms and laboratory findings of dengue fever, including positive NS1 and/or IgM serology results. During the course of illness these patients fail to show characteristic dengue symptoms, and two cases begin to show respiratory symptoms. Upon further investigation with chest X-ray or contact tracing, the patients were indicated for COVID-19 swab test, which yielded positive results. Repeat dengue IgM/IgG returned positive in one case, suggesting dengue coinfection; however in all other cases, the repeat testing returned negative, suggesting that the initial serologies were false positives. These cases highlight the importance of comprehensively studying patients with apparent dengue fever symptoms and serology, and using the appropriate adjuvant test according to the course of the disease, since a serological overlap may exist between the two diseases.
    Keywords covid19
    Language English
    Publishing date 2020-08-05
    Publishing country Netherlands
    Document type Case Reports
    ZDB-ID 2745454-X
    ISSN 2214-2509
    ISSN 2214-2509
    DOI 10.1016/j.idcr.2020.e00927
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Dengue serology in Indonesian COVID-19 patients

    Kembuan, Gabriele Jessica

    IDCases

    Coinfection or serological overlap?

    2020  Volume 22, Page(s) e00927

    Keywords covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2745454-X
    ISSN 2214-2509
    ISSN 2214-2509
    DOI 10.1016/j.idcr.2020.e00927
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?

    Kembuan, Gabriele Jessica

    IDCases

    Abstract: Dengue fever is an extremely common infection in Indonesia, with an estimated 77.96 cases / 100.000 person-years in 2016. However, in 2020 the threat of extremely contagious SARS CoV-2 or COVID-19 in Indonesia emerged, which has infected more than 100 ... ...

    Abstract Dengue fever is an extremely common infection in Indonesia, with an estimated 77.96 cases / 100.000 person-years in 2016. However, in 2020 the threat of extremely contagious SARS CoV-2 or COVID-19 in Indonesia emerged, which has infected more than 100.303 persons by July 28, 2020, and expected to grow exponentially except if very strict measures were implemented. There are similar symptoms and laboratory findings with both dengue fever and COVID-19, paving way to dangerous possibilities such as incorrect or delayed initial treatment. This is especially worrisome in the context of the pandemic, where COVID-19 positive patients must be promptly identified, isolated and contact-traced, and eluded diagnosis might possibly endanger communities and healthcare workers. We present cases of patients who initially presented with symptoms and laboratory findings of dengue fever, including positive NS1 and/or IgM serology results. During the course of illness these patients fail to show characteristic dengue symptoms, and two cases begin to show respiratory symptoms. Upon further investigation with chest X-ray or contact tracing, the patients were indicated for COVID-19 swab test, which yielded positive results. Repeat dengue IgM/IgG returned positive in one case, suggesting dengue coinfection; however in all other cases, the repeat testing returned negative, suggesting that the initial serologies were false positives. These cases highlight the importance of comprehensively studying patients with apparent dengue fever symptoms and serology, and using the appropriate adjuvant test according to the course of the disease, since a serological overlap may exist between the two diseases.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #694201
    Database COVID19

    Kategorien

  4. Article ; Online: Dengue serology in Indonesian COVID-19 patients

    Gabriele Jessica Kembuan

    IDCases, Vol 22, Iss , Pp e00927- (2020)

    Coinfection or serological overlap?

    2020  

    Abstract: Dengue fever is an extremely common infection in Indonesia, with an estimated 77.96 cases / 100.000 person-years in 2016. However, in 2020 the threat of extremely contagious SARS CoV-2 or COVID-19 in Indonesia emerged, which has infected more than 100 ... ...

    Abstract Dengue fever is an extremely common infection in Indonesia, with an estimated 77.96 cases / 100.000 person-years in 2016. However, in 2020 the threat of extremely contagious SARS CoV-2 or COVID-19 in Indonesia emerged, which has infected more than 100.303 persons by July 28, 2020, and expected to grow exponentially except if very strict measures were implemented. There are similar symptoms and laboratory findings with both dengue fever and COVID-19, paving way to dangerous possibilities such as incorrect or delayed initial treatment. This is especially worrisome in the context of the pandemic, where COVID-19 positive patients must be promptly identified, isolated and contact-traced, and eluded diagnosis might possibly endanger communities and healthcare workers.We present cases of patients who initially presented with symptoms and laboratory findings of dengue fever, including positive NS1 and/or IgM serology results. During the course of illness these patients fail to show characteristic dengue symptoms, and two cases begin to show respiratory symptoms. Upon further investigation with chest X-ray or contact tracing, the patients were indicated for COVID-19 swab test, which yielded positive results. Repeat dengue IgM/IgG returned positive in one case, suggesting dengue coinfection; however in all other cases, the repeat testing returned negative, suggesting that the initial serologies were false positives. These cases highlight the importance of comprehensively studying patients with apparent dengue fever symptoms and serology, and using the appropriate adjuvant test according to the course of the disease, since a serological overlap may exist between the two diseases.
    Keywords COVID-19 ; Dengue fever ; Serology ; Case series ; Infectious and parasitic diseases ; RC109-216 ; covid19
    Subject code 150
    Language English
    Publishing date 2020-01-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Correlation between heat shock protein 27 expression with estrogen receptor status in Indonesian breast cancer cases

    Gabriele Jessica Kembuan

    International Journal of Surgery and Medicine, Vol 6, Iss 3, Pp 1-

    2020  Volume 5

    Abstract: Introduction: Breast cancer is the second most common cancer in Indonesian women and the most common cancer in women worldwide. Estrogen receptors are one of the most prominent determinants of progressivity and prognosis in breast cancer. Meanwhile, the ... ...

    Abstract Introduction: Breast cancer is the second most common cancer in Indonesian women and the most common cancer in women worldwide. Estrogen receptors are one of the most prominent determinants of progressivity and prognosis in breast cancer. Meanwhile, the expression of heat shock proteins, including the downstream estrogen target Hsp27, are shown to be related with antiapoptotic and drug-resistant properties in cancer cells.This study aims to confirm whether Hsp27 overexpression is indeed correlated with estrogen receptor expression, and whether the correlation is statistically significant. Methods: This study was conducted on archived paraffin blocks of breast cancer tissue, dated from January to December 2015, and is a descriptive study complemented by statistical analysis. Results: The expression of estrogen receptors are found to be present in 63.33% of samples. Meanwhile, hsp27 expression scoring is equally divided, with 6.5 as the median score in a range of 0-13. Estrogen receptor expression and hsp27 expression are more prominent in patients aged older than 50 years old, as shown in cross-tabulation data. Spearman Rank Correlation test determines that the Hsp27 score is significantly correlated with staining intensity (p = 0.4209) and stained area (p = 0.044186) of estrogen receptor immunohistochemical status. Similarly, Wilcoxon Rank Sum statistics determines that there exists a statistically significant correlation between Hsp27 score and estrogen receptor positivity (p = 0.0369). Conclusion: The correlation between the expression of Hsp27 and estrogen receptor status is positive and statistically significant. Estrogen receptor positivity and high Hsp27 score are both more prominent in older aged patients.
    Keywords heat shock protein 27 ; estrogen receptor ; breast cancer ; Medicine ; R
    Subject code 616
    Language English
    Publishing date 2020-06-01T00:00:00Z
    Publisher Bulgarian Association of Young Surgeons
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Genetic retargeting of E3 ligases to enhance CAR T cell therapy.

    Lane, Isabel C / Kembuan, Gabriele / Carreiro, Jeannie / Kann, Michael C / Lin, William / Bouffard, Amanda A / Kreuzer, Johannes / Morris, Robert / Schneider, Emily M / Kim, Joanna Y / Zou, Charles / Salas-Benito, Diego / Gasser, Jessica A / Leick, Mark B / Słabicki, Mikołaj / Haas, Wilhelm / Maus, Marcela V / Jan, Max

    Cell chemical biology

    2023  Volume 31, Issue 2, Page(s) 338–348.e5

    Abstract: Chimeric antigen receptor (CAR) T cell therapies are medical breakthroughs in cancer treatment. However, treatment failure is often caused by CAR T cell dysfunction. Additional approaches are needed to overcome inhibitory signals that limit anti-tumor ... ...

    Abstract Chimeric antigen receptor (CAR) T cell therapies are medical breakthroughs in cancer treatment. However, treatment failure is often caused by CAR T cell dysfunction. Additional approaches are needed to overcome inhibitory signals that limit anti-tumor potency. Here, we developed bifunctional fusion "degrader" proteins that bridge one or more target proteins and an E3 ligase complex to enforce target ubiquitination and degradation. Conditional degradation strategies were developed using inducible degrader transgene expression or small molecule-dependent E3 recruitment. We further engineered degraders to block SMAD-dependent TGFβ signaling using a domain from the SARA protein to target both SMAD2 and SMAD3. SMAD degrader CAR T cells were less susceptible to suppression by TGFβ and demonstrated enhanced anti-tumor potency in vivo. These results demonstrate a clinically suitable synthetic biology platform to reprogram E3 ligase target specificity for conditional, multi-specific endogenous protein degradation, with promising applications including enhancing the potency of CAR T cell therapy.
    MeSH term(s) Humans ; Ubiquitin-Protein Ligases/metabolism ; Immunotherapy, Adoptive/methods ; Ubiquitination ; Neoplasms ; Transforming Growth Factor beta/genetics ; Transforming Growth Factor beta/metabolism
    Chemical Substances Ubiquitin-Protein Ligases (EC 2.3.2.27) ; Transforming Growth Factor beta
    Language English
    Publishing date 2023-11-20
    Publishing country United States
    Document type Journal Article
    ISSN 2451-9448
    ISSN (online) 2451-9448
    DOI 10.1016/j.chembiol.2023.10.024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top